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MicroRNAs (miRNAs) downregulate gene expression by binding to the partially complementary sites in the 3  untranslated region
(UTR) of target mRNAs. Several methods, such as Northern blot analysis, quantitative real-time RT-PCR, microarray, and the
luciferase reporter system, are commonly used to quantify the relative level or activity of miRNAs. The disadvantage of these
methods is the requirement for cell lysis, which means that several sets of wells/dishes of cells must be prepared to monitor changes
in miRNA activity in time-course studies. In this study, we developed a multisampling reporter system in which two secretable
bioluminescence-generating enzymes are employed, one as a reporter and the other as an internal control. The reporters consist of
a pair of vectors containing the Metridia luciferase gene, one with and one without a duplicated miRNA targeting sequence at their
3 UTR, while the other vector coding for the secreted alkaline phosphatase gene is used as an internal control. This method allows
miRNA activity to be monitored within the same population of cells over time by withdrawing aliquots of the culture medium.
The practicability and beneﬁts of this system are addressed in this report.
Copyright © 2009 Pei-Chen Huang et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
MicroRNAs (miRNAs) are small noncoding RNAs found
in plants and animals which downregulate gene expression
by binding to complementary sites on the 3  untranslated
region (UTR) of target mRNAs. As a result, the targeted
mRNAs are degraded if the miRNA and target sequence are
a perfect match or their translation is inhibited [1]. Over 800
diﬀerentmiRNAsarefoundinthehumangenome(miRBase:
http://microrna.sanger.ac.uk/; Sources of predicted miRNA
target: http://microrna.org), and each miRNA may have
hundreds of target mRNAs. For this reason, miRNAs have
profound eﬀects on global gene expression and are known to
play roles in various cellular processes, such as development,
diﬀerentiation, proliferation, and apoptosis [2–4].A number
of miRNAs have been linked to human cancer [1, 5].
Several methods are used to detect the relative level or
activity of miRNAs, including Northern blot analysis [6],
quantitativereal-timeRT-PCR[7],microarray[6,8],andthe
ﬁreﬂy luciferase reporter system [7, 9]. To circumvent the
tediousness and accuracy-compromising drawbacks of the
lysis of the test cells that is required in all the above methods,
in this study, we developed a multisampling reporter system
that makes it possible to monitor changes in miRNA activity
over time within the same population of cells by sampling
the culture medium, thus avoiding the need for a lysis step.
Brieﬂy, the system contains two distinct vectors that encode
diﬀerent secretable bioluminescence-generating enzymes.
The reporters consist of a pair of vectors containing the
Metridialuciferase(MLuc)genewithorwithoutaduplicated
miRNA targeting sequence at their 3 UTR, while the other
vector coding for the secreted alkaline phosphatase (SEAP)
gene is used as an internal control. The expression of all
three vectors is driven by the same SV40 promoter. MLuc,
a naturally secreted luciferase derived from Metridia longa
[10], oxidizes coelenterazine and produces luminescence.
Although placental alkaline phosphatase is a membrane-
bound protein, SEAP is genetically engineered and lacks
the membrane-anchoring domain [11]. The heat-resistant
SEAP hydrolyzes the substrate 1, 2-dioxetane and generates2 Journal of Biomedicine and Biotechnology
luminescence [12]. Taking advantage of these features, we
can sample small aliquots of medium over time and keep
the monitored cells intact. In this study, this system was
used to monitor the activity of miR-15/miR-16, which may
downregulate the expression of BCL-2, an antiapoptotic
protein [13, 14], by binding to their target sequence in the
3 UTR of the Bcl-2 gene [15, 16].
2.MaterialsandMethods
2.1. Plasmid Construction. The MLuc gene from the
pMetLuc-Control plasmid (Clotech Inc., Palo Alto, CA,
USA) was ampliﬁed by PCR using the forward primer
5 -CGAAGCTTATGGACATCAAGGTGGTG-3  and the
reverse primer 5 -TATGATCTAGAGTCGCGG-3  (HindIII
and XbaI restriction sites are indicated in bold letters).
The amplicon was cut by HindIII and XbaI. pGL3-
Control (Promega Inc., Madison, WI, USA) was cut
using the same restriction enzymes to remove the ﬁreﬂy
luciferase gene, and the MLuc amplicon was inserted.
The recombinant vector was designated pMLuc. Two
complementary oligonucleotides 5 TCTAGAAATATCCAA
TCCTGTGCTGCTATCCTGCCAACAATATCCAATCCTGT
GCTGCTATCTAGA3  and 5 AGATCTTTATAGGTTAGG
ACACGACGATAGGACGGTTGTTATAGGTTAGGACA
CGACGATAGATC3  containing two miR15/miR-16 target
sequences (the 3 UTR target site in human Bcl-2 mRNA),
indicated in bold letters, were annealed. The double-
stranded oligonucleotide was inserted into the XbaI site of
pMLucwhichislocateddownstreamofthestop codon ofthe
MLuc gene. The recombinant vector obtained was named
pMLuc-UTR. pSEAP2-Control (Clotech Inc.) containing
the SEAP gene was used as an internal control.
2.2. Pre-miRNA. Pre-miR-16 and the negative control pre-
miR (NC miR) were purchased from Ambion (Austin, TX,
USA).
2.3. Cell Culture and Transfection. HEK293T and HepG2
cells (purchased from the Bioresource Collection and
Research Center, Taiwan) were cultured in DMEM con-
taining 10% fetal bovine serum (both from Gibco BRL,
Gaithersburg, MD, USA) at 37
◦C in a humidiﬁed CO2
incubator. For transfection, the cells were grown in 6-well
plates to 70% conﬂuence. Transfection with plasmids and
pre-miRNA was performed using a previously described
protocol [17].
2.4. Assays of MLuc and SEAP Activity. Culture medium was
collected and centrifuged, then 20μL aliquots of the cell-
free medium diluted in 180μL of 0.9% NaCl were assayed
for MLuc and SEAP activity using kits purchased from
Clotech. For the MLuc assay, the 10× MLuc substrate stock
was diluted to 1× in reaction buﬀer then diluted to 0.5×
in double-distilled H2O; then 5μL of the substrate/buﬀer
solution and 50μL of the diluted sample were mixed and
loaded in 96-well black plates to detect luminescence. For
the SEAP assay, 30μLo f1 × dilution buﬀer and 10μLo f
the diluted sample were mixed and incubated at 65
◦Cf o r
30 minutes and 4◦C for 2 minutes in 96-well black plates,
then 40μL of SEAP substrate solution was added and the
samples incubated at room temperature for 30 minutes
before detecting the luminescence.
2.5. Quantiﬁcation of miR-16 by qRT-PCR. HepG2 cells were
grown in 6 cm Petri dishes to 70% conﬂuence then were
treated for diﬀerent periods with 100μM epigallocatechin
gallate(EGCG).TotalRNAwasextractedfromthecellsusing
Trizol reagent (Invitrogen). qRT-PCR analysis for miRNAs
was performed using TaqMan MicroRNA assays kit (Applied
Biosystem, Foster City, CA, USA). Fifty nanograms of total
RNAweresubjectedtoreversetranscription(RT)usingmiR-
16 and U6 RT primers (has-miR-16 UAGCCAGCACGU-
AAAUAUUGCG; U6 CGCAAGGAUGACACAC GCAAAU-
UCGUG AAGCGUUCCAUAUUUUU) purchased from
Applied Biosystem. RT was performed on a PCR machine
(16
◦C for 30 minutes, 42
◦Cf o r3 0m i n u t e s ,a n d8 5
◦Cf o r
5 minutes). Real-time PCR was performed using an ABI
PRISM 7900 (Applied Biosystem) and speciﬁc primer sets
for miR-16 and U6 RNAs from Applied Biosystem. The
conditions for the real-time PCR were 95
◦Cf o r1 0m i n u t e s
and 40 cycles of 95
◦C for 30 seconds and 60
◦Cf o r1m i n u t e .
The ΔCt was calculated by subtracting the Ct for U6 small
nuclear RNA from that for miR-16. The ΔΔCt was calculated
bysubtractingtheΔCtfortheuntreatedcontrolfromthatfor
the EGCG-treated sample. The fold change in miR-16 levels
was calculated as log 2−ΔΔCt.
3. Results and Discussion
To monitor the activity of miRNA in vivo without destroying
the test cells, we devised a secretable reporter system con-
sisting of three vectors that allows accurate and continuous
measurement of the test miRNA. All 3 vectors (pMLuc,
pMLuc-UTR, and pSEAP2-Control) were designed to use
the same SV40 promoter to regulate the expression of the
reporters or the internal control. pSEAP2-Control serves
the dual role of (1) normalizing the transfection eﬃciency
and (2) normalizing the activity of the SV40 promoter,
which may diﬀer in the context of various treatments. We
ﬁrst examined the signal-to-noise (background) ratio of
the system and the stability of the two enzymes in culture
medium to freeze thawing to determine whether samples
from a time-course study could be frozen then assayed
simultaneously. To examine these parameters, HEK293T
cells were transfected with pMLuc or pSEAP2-Control, then
1mL of culture medium was withdrawn 24 hours after
transfection and centrifuged. The cell-free medium was then
incubated at 37
◦Ci naC O 2 incubator and 20μL aliquots
were withdrawn at diﬀerent time points and assayed for
MLuc or SEAP activity. The results, shown in Figure 1(a),
indicate that the background signals from DMEM and
conditioned medium from nontransfected cells were <0.1%
of that from conditioned medium from pMLuc- or pSEAP2-
Control-transfected cells. The secreted enzymes were stableJournal of Biomedicine and Biotechnology 3
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Figure 1: Characterization of the multisampling reporter system. HEK293T cells were grown in 6-well plates to 70% conﬂuency, then some
were left untreated and others were transfected with 0.5μg of pMLuc or pSEAP2-Control for 24 hours. (a) An aliquot of the medium was
assayed for MLuc (left) or SEAP (right). (b) The culture medium was collected and incubated at 37
◦Ci na5 %C O 2 humidiﬁed chamber and
aliquots were withdrawn at diﬀerent time points and assayed for MLuc (left) or SEAP (right). (c) Medium samples were frozen at −20
◦Ci n
separate Eppendorf tubes, and thawed at the indicated times, and assayed. The data presented are the mean ± SD of triplicates.
in culture medium at conditions of 37
◦C and 5% CO2 for
severalhours(Figure 1(b)).Asinglefreezethawcyclereduced
MLuc activity by 20%, but activity was not further reduced
by freezing for 7 days (Figure 1(c)). Freeze-thaw and freezing
for 7 days had no eﬀect on SEAP activity (Figure 1(c)). This
shows that we can collect and freeze all the samples from a
single experiment and test them later without compromising
the accuracy of the results. Thus, MLuc and SEAP are
practicable for a multisampling reporter assay.
To test whether our system faithfully reﬂected the
cellular activity of miR-15/miR-16, HEK293T cells were
cotransfected with pSEAP2-Control, pMLuc or pMLuc-
UTR, and pre-miR-16 or NC miR. The culture medium was
replaced with fresh medium at 16, 24, and 36 hours after
transfection and aliquots of medium were taken 2 hours
after each medium change and assayed for MLuc and SEAP.
The MLuc/SEAP activity ratios after various treatments are
shown in Figure 2(a). The results showed that the ratios for
the pMLuc-UTR + pre-miR-16 group (black bars) were 2-
to 3-fold lower than those for the pMLuc-UTR + NC miR
group (gray bars), indicating that pre-miR-16 suppressed the
expression of Mluc. In addition, the ratios for the pMLuc-
UTR + NC miR group (gray bars) were 1.5-fold lower than
those for the pMLuc + NC miR group (white bars). This is
because endogenous miR-15/miR-16 can target the MLuc-
UTR mRNA generated from pMLuc-UTR. Cotransfection
with pMLuc, which does not contain miR-15/miR-16 target
sites, resulted in a higher ratio. These results indicate that
our reporting system can be used to detect miR-15/miR-
16 activity without disrupting the cells. The fourth group
pMLuc + pre-miR-16 (hatched bars) showed higher ratios
than those of the pMLuc + NC miR group (white bars),
but a similar trend. This may be due to some global eﬀect
of miR-16 on the treated cells. In addition, by monitoring4 Journal of Biomedicine and Biotechnology
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Figure 2:Reportingabilityofthemultisamplingreportersystem.HEK293Tcellsweregrownin6-wellplatesto70%conﬂuency.(a)Thecells
were cotransfected with 0.5μg of pSEAP2-Control, 0.5μg of pMLuc or pMLuc-UTR, and 30nM pre-miR-16 or NC miR. The medium was
replaced with fresh medium at diﬀerent time points after transfection, and an aliquot of medium was withdrawn 2 hours later and assayed
f o rM L u ca n dS E A P .( b )T h ec e ll sw e r ec o tra n s f e ct e dwi t h0 . 5μg of pMLuc-UTR and pSEAP2-Control, together with diﬀerent concentration
of pre-miR-16 (0–35nM) and NC miR (35–0nM), then, 24 hours later, an aliquot of medium was withdrawn from each culture medium
and assayed. The data presented are the mean ± SD of triplicates.
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Figure 3: Increase in miR-16 activity after EGCG treatment of HepG2 cells. HepG2 cells were grown in 5mL of DMEM in 6cm Petri dishes
to 70% conﬂuency. (a) The cells were cotransfected for 6 hours with 4μg of pMLuc or pMLuc-UTR and 4μg of pSEAP2-Control, then
5μL of 100mM of EGCG (dissolved in DMSO) or DMSO was added. The medium was replaced with fresh medium at 24 and 36 hours
and an aliquot of medium was withdrawn 2 hours later and assayed for MLuc and SEAP. The fold repression is deﬁned as the MLuc (from
pMLuc)/SEAP ratio divided by the MLuc (from pMLuc-UTR)/SEAP ratio. (b) The cells were treated with or without EGCG for 24 or 36
hours, then total RNA was extracted and subjected to qRT-PCR to detect levels of miR-16 and U6 small nuclear RNA (see Section 2 for
details). The data presented are the mean ± SD of triplicates; ∗P<. 05.
the same population of cells at 16, 24, and 36 hours, we
found that the diﬀerence between the pMLuc-UTR + NC
miR group ratios (gray bars) and the pMLuc-UTR + pre-
miR-16 group ratios (black bars) decreased from 2.9-fold
to 2.4-fold, then to 2.2-fold. This suggests that there is a
gradual reduction in miR-16 levels in cells with time. To test
the sensitivity of our reporting system, HEK293T cells were
cotransfected with pMLuc-UTR + pSEAP2-Control, and
diﬀerent concentrations of pre-miR-16 and NC miR (total
concentration of the two 35nM) and aliquots of medium
were taken 24 hours after transfection and assayed for MLuc
and SEAP activity. As shown in Figure 2(b),d o s e - d e p e n d e n t
suppression of MLuc was seen in response to an increasing
amount of pre-miR-16.
HepG2, a liver cancer cell line, is known to exhibit
upregulation of miR-16 levels (1.5-fold) following treatment
with epigallocatechin gallate (EGCG) [18]. We, therefore,
used our reporter system to monitor changes in this
endogenous miRNA. HepG2 cells were cotransfected with
pSEAP2-Control and either pMLuc-UTR or pMLuc then
wereculturedinthepresenceorabsenceofEGCG.Theresult
is shown in Figure 3, in which “fold repression” is deﬁned asJournal of Biomedicine and Biotechnology 5
the MLuc (from pMLuc)/SEAP ratio divided by the MLuc
(from pMLuc-UTR)/SEAP ratio. A signiﬁcant increase in
fold repression was seen in 24 hours of EGCG treatment
compared to the blank control. A concomitant increase in
miR-16 levels was conﬁrmed by quantitative real-time RT-
PCR (Figure 3(b)). The role of miRNA in ﬁne tuning of
protein synthesis can be elicited from the results of Figures
2(b) and 3. We have used our system to screen compounds
whichmightup-ordown-regulateagivenmiRNA.However,
we found that some compounds had a direct eﬀect on the
enzymaticactivitiesofMLucand/orSEAP,leadingtochanges
in the MLuc/SEAP ratio, while miRNA activities remained
unchanged. We overcame this potential fault by calculating
the fold repression instead of the MLuc/SEAP ratio, as the
MLucand SEAP activities werenormalized in thecalculation
of the fold repression. We, therefore, strongly favor using the
fold repression data for drug screening.
4. Conclusions
Our pMluc/pSEAP2-Control-based reporter facilitates mul-
tisampling for monitoring the activity of a given miRNA
using culture medium. The extracellular reporters are less
aﬀected by intracellular modiﬁcations. Time-course studies
can be performed using the same population of cells.
Samples collected at constant interval after each medium
refreshing provide an activity readout of a given miRNA in
real time. Moreover, the same population of cells used in
detecting miRNA activity can be used for RNA extraction for
further determination of miRNA levels. This method oﬀers
the beneﬁts of accuracy, convenience, and cost eﬀectiveness.
With no need for cell lysis or addition of protease inhibitors,
our system is more applicable to robust high-throughput
drug screening. Finally, the system is versatile, as it can
be easily switched to monitor the activity of any given
miRNA by inserting diﬀerent synthesized miRNA-targeting
sequences into the XbaI site of pMluc.
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